1M6MYTD1Y5YMAX
Loading quotes...
Forecast
The analysts' average price target is €2.77 (+295.71%). The median is €2.77 (+295.71%).
| Buy |
5 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 1.07M | 57.53% |
| Gross profit | 169.98K | 91.83% |
| Net profit | -11.11M | 25.85% |
| EBITDA | -10.7M | 26.10% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €52.88K |
Number of shares | 66.64K |
52-week high/low | €73.71 - €0.63 |
| Dividends | No |
Beta | -0.05 |
P/E ratio | 0.00 |
PEG ratio | 0.00 |
P/B ratio | 0.11 |
P/S ratio | 0.00 |
Company profile
| Name | Jaguar Health |
| CEO | Lisa A. Conte |
| Employees | 47 |
Discover assets
Shareholders of Jaguar Health also invest in the following assets
